Rs 21 Dividend Soon By Healthcare Stock: Record Date Confirmed; Buy The Stock On Wednesday, 9th July?

One of the leading providers of diagnostic and preventive healthcare services in India is Thyrocare Technologies Limited. Thyrocare focuses on providing high-quality, reasonably priced diagnostic testing through a centralized, automated laboratory in Mumbai as well as regional laboratories throughout India and other areas of Asia. With a significant presence in more than 2000 cities and towns, Thyrocare Technologies Limited is India's first and most sophisticated completely automated laboratory.

Thyrocare Technologies Dividend

"In furtherance to our letter dated April 23, 2025, wherein it was intimated that the Board of Directors, at its meeting held on Wednesday, April 23, 2025, had recommended a final dividend of Rs 21/- per equity share of face value Rs 10/- each, for approval by the shareholders at the Annual General Meeting ("AGM") scheduled to be held on July 31, 2025. Pursuant to Regulation 42 of the Listing Regulations, the Company has fixed Friday, July 25, 2025, as the Record Date for determining the entitlement of Members to receive the final dividend for the financial year ended March 31, 2025. If the dividend, as recommended by the Board, is approved at the AGM, the payment of such dividend, subject to deduction of tax at source, will be made on or before August 30, 2025," said Thyrocare Technologies in a stock exchange filing.

Thyrocare Technologies Dividend History & Yield

Over the previous few years, Thyrocare Technologies has consistently paid dividends. According to indmoney.com, the firm paid an annual dividend of Rs 18 per share in FY 2023-2024 (paid in August 2024), yielding around 1.76% based on a share price of Rs 1,023 as of July 7, 2025. Digrin predicts a forward yield of about 1.82% based on consistent Rs 18 payouts, whereas more recent data from Trendlyne shows a comparable dividend of Rs 18 and a yield of 1.76%.

Thyrocare's dividend payouts have historically climbed gradually. According to Trendlyne, it increased from Rs 2.5 in FY 2016 to Rs 5 in 2017-18, Rs 10 in 2020, and Rs 15 in 2021-22 before hitting Rs 18 in 2023-24. Thyrocare is distinct from its competitors in the sector. According to Simply Wall St and Trendlyne statistics, Thyrocare's ~1.8% yield is 2-3× higher than the overall healthcare average and 4-6× higher than its diagnostics rivals. The average one-year dividend yield in the BSE Healthcare index is around 0.63-0.73%. In conclusion, compared to industry comparisons, Thyrocare Technologies offers excellent income potential, a robust dividend yield (~1.8%), and steady payment growth.

Thyrocare Technologies Share Price Target

"Thyrocare is trading with a sideways to mildly bullish bias. Support is placed near ₹1,020, while resistance lies at ₹1,100. A breakout above ₹1,100 could take the stock toward ₹1,160. The stock is holding above key moving averages, indicating underlying strength. A close below ₹1,020 may weaken the structure," commented Riyank Arora, technical analyst at Mehta Equities Ltd.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.